Profound Medical

PROF · TORONTO

$5.56−$0.20 (−3.47%)TodayMarket closed ·
Prev close $5.76

Latest news

  • Press releaseGlobe Newswire

    Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar

  • Press releaseGlobe Newswire

    TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity

  • Press releaseGlobe Newswire

    Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

  • Press releaseGlobe Newswire

    Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue

  • Press releaseGlobe Newswire

    Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President

  • Press releaseGlobe Newswire

    Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’

  • Press releaseGlobe Newswire

    Profound Medical Announces Management Change

  • Press releaseGlobe Newswire

    Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey

  • Press releaseGlobe Newswire

    Profound Medical Reports Second Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial

  • Press releaseGlobe Newswire

    Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

  • Press releaseGlobe Newswire

    Profound Medical Reports Strong First Quarter 2026 Financial Results

  • Press releasePRNewswire

    Why Medtech Giants Are Quietly Paying Up for AI Diagnostics

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • News

    Profound Medical Q4 Earnings Assessment

  • News

    Earnings Summary: Profound Medical Q4

  • Press releaseGlobe Newswire

    Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results

  • News

    Earnings Scheduled For March 5, 2026

  • News

    Profound Medical's Earnings: A Preview

  • News

    Profound Medical Announces First Prostate Cancer Patient Treated With TULSA-PRO At Mount Sinai Hospital

  • Press releaseGlobe Newswire

    Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

  • News

    Earnings Scheduled For November 13, 2025

  • Press releaseGlobe Newswire

    Profound Medical to Participate in the Stifel 2025 Healthcare Conference

  • Press releaseGlobe Newswire

    Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter

  • Press releaseGlobe Newswire

    Profound Medical Announces Second Quarter 2025 Financial Results

  • News

    Earnings Scheduled For August 14, 2025

  • NewsAvi Kapoor

    Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    Profound Medical Announces First Quarter 2025 Financial Results

  • News

    Earnings Scheduled For May 8, 2025

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releasePRNewswire

    PROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law Firm

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releasePRNewswire

    PROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law Firm

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Profound Medical Corp. – PROF

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • Press releaseGlobe Newswire

    Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

  • NewsAvi Kapoor

    Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.